Citigroup’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-29,900
Closed -$996K 5695
2024
Q4
$996K Sell
29,900
-269,000
-90% -$8.73M ﹤0.01% 3373
2024
Q3
$7.76M Buy
298,900
+269,000
+900% +$6.69M ﹤0.01% 1489
2024
Q2
$672K Hold
29,900
﹤0.01% 3198
2024
Q1
$710K Buy
+29,900
New +$665K ﹤0.01% 3304
2021
Q1
Sell
-46,300
Closed -$929K 6598
2020
Q4
$929K Buy
46,300
+300
+0.7% +$6.28K ﹤0.01% 3609
2020
Q3
$1.13M Buy
46,000
+10,500
+30% +$245K ﹤0.01% 3164
2020
Q2
$843K Sell
35,500
-2,400
-6% -$55.6K ﹤0.01% 3736
2020
Q1
$653K Sell
37,900
-39,200
-51% -$717K ﹤0.01% 3617
2019
Q4
$1.36M Sell
77,100
-6,500
-8% -$110K ﹤0.01% 3423
2019
Q3
$1.48M Buy
83,600
+2,500
+3% +$50.6K ﹤0.01% 3197
2019
Q2
$1.73M Buy
81,100
+35,200
+77% +$738K ﹤0.01% 3022
2019
Q1
$1.09M Sell
45,900
-7,100
-13% -$162K ﹤0.01% 3302
2018
Q4
$1.04M Buy
53,000
+5,200
+11% +$92.7K ﹤0.01% 3344
2018
Q3
$847K Sell
47,800
-9,700
-17% -$189K ﹤0.01% 3681
2018
Q2
$1.24M Buy
57,500
+2,400
+4% +$49.6K ﹤0.01% 3131
2018
Q1
$1.22M Sell
55,100
-6,200
-10% -$171K ﹤0.01% 3067
2017
Q4
$1.86M Buy
61,300
+10,200
+20% +$271K ﹤0.01% 2743
2017
Q3
$1.24M Sell
51,100
-39,400
-44% -$1.05M ﹤0.01% 3142
2017
Q2
$2.23M Buy
90,500
+29,300
+48% +$620K ﹤0.01% 2480
2017
Q1
$1.33M Buy
61,200
+50,900
+494% +$1.04M ﹤0.01% 2912
2016
Q4
$154K Sell
10,300
-1,000
-9% -$14.4K ﹤0.01% 5494
2016
Q3
$145K Buy
11,300
+900
+9% +$9.73K ﹤0.01% 4919
2016
Q2
$81K Buy
10,400
+8,700
+512% +$50.1K ﹤0.01% 5250
2016
Q1
$7K Sell
1,700
-4,400
-72% -$18.6K ﹤0.01% 6900
2015
Q4
$34K Buy
6,100
+2,700
+79% +$15.1K ﹤0.01% 6190
2015
Q3
$19K Buy
3,400
+1,300
+62% +$7.07K ﹤0.01% 6062
2015
Q2
$8K Buy
+2,100
New +$6.83K ﹤0.01% 6558

Other funds holding EXEL

Citigroup's EXEL Position: Q1 2026 in Review

Citigroup reduced its Exelixis (EXEL) stake by 3.3% in Q1 2026, selling an estimated $220K and leaving 149,846 shares worth $6.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1774.

Citigroup first reported a position in EXEL in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.7M in Q2 2025. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Citigroup held 149,846 shares of Exelixis worth $6.43M as of Q1 2026.
  • Citigroup sold 5,125 Exelixis shares in Q1 2026, an estimated $220K.
  • Exelixis made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #1774 holding.
  • Citigroup first reported a position in Exelixis in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Exelixis position peaked at $30.7M in Q2 2025.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.